March 3, 2021
Business News

Genus plc Provides Update on Financial Performance for First Half of Fiscal 2021

BASINGSTOKE, England & MADISON, Wis.–()–Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the six-months period ending December 31, 2020.

The strong trading performance reported by the Company at its recent Annual General Meeting (AGM) on November 25, 2020 has continued through the first half of Genus’s financial year, and the adjusted profit before tax of the Group in actual currency is now expected to be within a range of £47.0m and £49.0m for the first half (six months to December 31, 2019: £36.6m). Revenue for the period is now expected to be within a range of £285.0m to £287.0m (six months to December 31,…

Click here to view the original article.

Related Posts

You might also like ...

PoliteMail Internal Communications Benchmark Report Reveals 72% Increase in Corporate Email Volume in 2020
AM Best to Join Panel at Midwest Actuarial Forum’s Spring Meeting
XPeng Launches New LFP-Battery Powered Vehicles, Expanding Product Offering for Diversified Customer Needs